News from zhejiang hisun pharmaceutical co. ltd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 26, 2020, 10:00 ET Zhejiang Hisun Pharmaceutical Co., Ltd.: Free of COVID-19, Governments Suggest Favipiravir

Favipiravir is a broad-spectrum antiviral agent that inhibits the RNA-dependent RNA polymerase of RNA viruses. It has efficacy against a range of RNA ...


Jun 25, 2020, 12:33 ET Zhejiang Hisun Pharmaceutical Co. Ltd: Triunfa do COVID-19, governos sugerem Favipiravir

O Favipiravir é um agente antiviral de largo espectro que inibe a RNA polimerase dependente do RNA viral. Tem eficácia contra Ebola, gripe e COVID-19....


Jun 25, 2020, 12:30 ET Zhejiang Hisun Pharmaceutical Co. Ltd: Favipiravir, eficaz para tratar pacientes con COVID-19

Favipiravir es un antiviral inhibidor de la RdRp de amplio espectro, tiene eficacia contra virus como la influenza, el COVID-19 y el Ébola, no ha...


Jun 23, 2020, 10:32 ET Hisun Pharmaceutical: Free of COVID-19, Governments Suggest Favipiravir

Favipiravir is a broad-spectrum antiviral agent that inhibits the RNA-dependent RNA polymerase of RNA viruses. It has efficacy against a range of RNA ...


Jun 22, 2020, 14:13 ET Hisun Pharmaceutical: Free of COVID-19, Governments Suggest Favipiravir

Favipiravir is a broad-spectrum antiviral agent that inhibits the RNA-dependent RNA polymerase of RNA viruses. It has efficacy against a range of RNA ...